{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:14:28Z","timestamp":1758816868029},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,5,13]],"date-time":"2003-05-13T00:00:00Z","timestamp":1052784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is evidence that glucocorticoids mediate the activity of mesencephalic dopaminergic neurons which play an important role in drug\u2010seeking behaviour and that the absence or presence of glucocorticoids determines the intensity of drug self\u2010administration. Moreover, some experiments indicate that corticoids are increased after substance induced dopaminergic stimulation. These findings could imply (a) that differences in basal glucocorticoid levels are associated with differences in craving or (b) that dopamine (DA) induced corticoid release is an indicator of the sensitivity of the dopaminergic system.<\/jats:p><jats:p>Therefore, in a sample of 36 male smokers whose DA system was challenged by a DA agonist (lisuride\u2009=\u2009LIS) and a DA antagonist (fluphenazine\u2009=\u2009FLU) in a balanced placebo controlled double\u2010blind crossover design, it was investigated if (a) basal cortisol differences and (b) drug induced cortisol responses are related to the amount of nicotine craving after 3.5\u2009h of deprivation from smoking.<\/jats:p><jats:p>There were no differences in craving between subjects with high and low basal cortisol levels irrespective of the pharmacological treatment. However, the size of the cortisol change after the DA challenge and deprivation emerged as a good predictor for the amount of craving in that drug condition in which the cortisol response was most pronounced.<\/jats:p><jats:p>Findings were interpreted as evidence for the role of cortisol as an indicator of DA sensitivity. Copyright \u00a9 2003 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hup.503","type":"journal-article","created":{"date-parts":[[2003,8,12]],"date-time":"2003-08-12T15:25:57Z","timestamp":1060701957000},"page":"437-446","source":"Crossref","is-referenced-by-count":10,"title":["Cortisol as an indicator of dopaminergic effects on nicotine craving"],"prefix":"10.1002","volume":"18","author":[{"given":"M.","family":"Reuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,5,13]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.207"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2000.10736099"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.242"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14622200210153830"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700016160"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245149"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1901\/jeab.1993.59-483"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb03041.x"},{"key":"e_1_2_1_10_1","first-page":"1401","article-title":"Glucocorticoids and behavioral effects of stimulants. II: cocaine intravenous self\u2010administration and reinstatement depend on glucocorticoid levels","volume":"281","author":"Deroche V","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90068-2"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558250"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.5.1310"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00423-X"},{"key":"e_1_2_1_15_1","first-page":"59","volume-title":"Neuroleptika (Neuro\u2010Psychopharmaka, Vol. 4)","author":"Fritze J","year":"1992"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177706545"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00206-5"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199302000-00001"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246221"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1510439"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(89)90269-4"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(85)90079-6"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00195-0"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00278591"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513599709152529"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(93)90055-E"},{"key":"e_1_2_1_27_1","first-page":"473","volume-title":"The Mesolimbic Dopamine System: From Motivation to Action","author":"Piazza PV","year":"1991"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.36.040196.002043"},{"key":"e_1_2_1_29_1","first-page":"277","article-title":"Stress, glucocorticoids, and mesencephalic dopaminergic neurons: a pathophysiological chain determining vulnerability to psychostimulant abuse","volume":"163","author":"Piazza PV","year":"1996","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_1_30_1","unstructured":"PiazzaPV Roug\u00e9\u2010PontF DerocheV KharoubyM Le MoalM SimonH.1993.Corticosterone sensitivity to drugs of abuse: role of doamine release. InAnnual Meeting of the Society of Neuroscience Washington DC November7\u201312."},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.402"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00329-3"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-34118"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.11.1393"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.4.632"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348453"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(99)01447-2"},{"key":"e_1_2_1_38_1","volume-title":"Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl SM","year":"2000"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.29.185"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90518-X"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01732.x"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1250385"},{"key":"e_1_2_1_43_1","unstructured":"World Medical Association.2000.World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects. Ferney\u2010Voltaire WMA http:\/\/www.wma.net\/e\/policy\/17\u2013c_e.html"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.503","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:45:38Z","timestamp":1700239538000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,13]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1002\/hup.503"],"URL":"https:\/\/doi.org\/10.1002\/hup.503","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,13]]}}}